SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

SNAP is trending after a post-earnings sell-off, with the community actively debating whether strong quarterly results and a share buyback are overshadowed by persistent concerns about high stock-based compensation and dilution, amid long-term optimism for AI/AR innovations.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is trending following a significant post-earnings stock drop, which the community largely attributes to an overreaction to mixed Q4 results featuring a revenue miss but strong profitability and conservative future guidance. Many investors highlight the company's solid fundamentals, shift towards prudent risk management, and attractive valuation as reasons for its current undervaluation amidst broader fintech sector headwinds.

Kyndryl Holdings, Inc. is a technology services company, which engages in the provision of infrastructure services. It operates through the following segments: United States, Japan, Principal Markets, and Strategic Markets. The Principal Markets segment represents the aggregation of operations in Australia, New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, the United Kingdom, and Ireland. The company was founded on December 4, 2020 and is headquartered in New York, NY.

Kyndryl Holdings Inc

Kyndryl Holdings is plummeting after the abrupt departures of its CFO and general counsel amid an SEC accounting investigation, sparking intense community discussion on whether the severe market reaction presents a bargain opportunity or signals deeper issues akin to prior corporate collapses.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Regenxbio is trending following the FDA's Complete Response Letter for its RGX-121 gene therapy for Hunter syndrome, citing issues with trial design and the use of natural history controls. The community is now intensely discussing the severe financial impact on the company and potential ramifications for its other gene therapy programs and the broader sector.

Fefe is a memecoin inspired by Matt Furie's book "Mindviscosity," published in 2020.  Follow FEFE, the alter ego of PEPE in the book “Mindviscosity” by Matt Furie.  Fefe is a main character in the book, who is a laid back and carefree frog living in a whimsical world. Fefe's relaxed and adventurous spirit captures the heart of this imaginative universe.  Launched stealth with no presale, zero taxes, LP burnt and contract renounced - TAX: 0/0 This narrative has its roots in a fascinating story.  Join us and become part of the $FEFE community today!

Fefe

FEFE CRYPTO is trending for its notable resilience and positive price action in a challenging market, driven by a dedicated community actively accumulating and promoting its narrative as the "third frog" and literal representation of Pepe by creator Matt Furie. Despite some labeling it a scam, proponents are confident in its organic growth and potential as a prime frog meta beta play.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is seeing intense discussion around its pivotal role in the AI-nuclear nexus, fueled by its power development partnership with Meta and anticipated DOE plutonium awards, though persistent insider selling and its pre-revenue status are generating fierce debate and price swings.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. TeraWulf will generate domestically produced bitcoin powered by nuclear, hydro and solar energy. The company was founded by Paul Prager and Nazar Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf (WULF) is trending after Morgan Stanley initiated coverage with an Overweight rating and a $37 price target, fueling community excitement over its strategic pivot to AI data centers and potential for a short squeeze. Investors are actively discussing the company's valuable power infrastructure and strategic partnerships, positioning it for significant growth beyond Bitcoin mining.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is trending as it opens its 30,000th store, including a new premium flagship, coinciding with rival Cotti Coffee reportedly ending its aggressive discount strategy. This development is driving community discussions around potential margin expansion and the company's significant undervaluation compared to competitors.

Invesco DB US Dollar Index Trust - Invesco DB US Dollar Index Bullish Fund

Invesco DB US Dollar Index Bullish Fund

The Invesco DB US Dollar Index Bullish Fund (UUP) is trending as the US dollar faces pressure from widespread expectations of future Fed rate cuts and a broader "risk-on" market sentiment favoring equities and commodities. The community is discussing a potential dollar breakdown, with some linking weakness to de-dollarization concerns and a surge in precious metals like gold and silver.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as the FDA's swift action against compounded GLP-1s from Hims & Hers validates legitimate drug development, amplifying speculation that Viking's "best-in-class" VK2735 is a critical acquisition for companies like Novo Nordisk, which face intense competition from Eli Lilly in the booming obesity market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mark Schoenberg Sells 7,373 Shares of Urogen Pharma (NASDAQ:URGN) Stock

Urogen Pharma (NASDAQ:URGN - Get Free Report) insider Mark Schoenberg sold 7,373 shares of the business's stock in a transaction dated Tuesday, February 3rd. The stock was sold at an average price of...

Urogen Pharma (NASDAQ:URGN) Given Average Rating of "Moderate Buy" by Brokerages

Urogen Pharma (NASDAQ:URGN - Get Free Report) has received an average recommendation of "Moderate Buy" from the nine ratings firms that are presently covering the firm, MarketBeat reports. One...

Privium Fund Management B.V. Increases Stock Position in Urogen Pharma $URGN

Privium Fund Management B.V. lifted its holdings in Urogen Pharma (NASDAQ:URGN - Free Report) by 82.7% during the third quarter, according to its most recent 13F filing with the Securities and...

Urogen Pharma (NASDAQ:URGN) Given Buy Rating at D. Boral Capital

D. Boral Capital reissued a "buy" rating and issued a $33.00 target price on shares of Urogen Pharma in a report on Friday...

Harel Insurance Investments & Financial Services Ltd. Trims Holdings in Urogen Pharma $URGN

Harel Insurance Investments & Financial Services Ltd. decreased its holdings in shares of Urogen Pharma (NASDAQ:URGN - Free Report) by 47.5% in the 3rd quarter, according to its most recent Form 13F...

Urogen Pharma (NASDAQ:URGN) Shares Down 6.5% - What's Next?

Urogen Pharma (NASDAQ:URGN) Stock Price Down 6.5% - Time to Sell...

D. Boral Capital Reiterates "Buy" Rating for Urogen Pharma (NASDAQ:URGN)

D. Boral Capital restated a "buy" rating and set a $33.00 target price on shares of Urogen Pharma in a research report on Monday...

Urogen Pharma $URGN Shares Purchased by Squarepoint Ops LLC

Squarepoint Ops LLC raised its position in Urogen Pharma (NASDAQ:URGN - Free Report) by 187.8% during the second quarter, according to the company in its most recent 13F filing with the Securities...

Urogen Pharma Target of Unusually Large Options Trading (NASDAQ:URGN)

Urogen Pharma (NASDAQ:URGN - Get Free Report) was the target of some unusual options trading activity on Wednesday. Stock investors acquired 20,427 call options on the company. This represents an...

Urogen Pharma (NASDAQ:URGN) Stock Price Up 6.4% - Still a Buy?

Urogen Pharma (NASDAQ:URGN) Stock Price Up 6.4% - Still a Buy...

UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.

UroGen Pharma Ltd

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $HOOD earnings on Tuesday?

URGN
UroGen Pharma Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest URGN News

URGNUroGen Pharma Ltd